Evidence map›Paper›PMID 39660656›Full record

SynthesisHuman vaccines & immunotherapeutics2024

How has co-design been used to address vaccine hesitancy globally? A systematic review.

Filipa Alpeza, Helena Avermark, Elisa Gobbo, Sibylle Herzig van Wees

Abstract readSystematic Review
In one paragraph

Synthesis in Human vaccines & immunotherapeutics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Filipa AlpezaDepartment of Global Public Health, Karolinska Institutet, Stockholm, Sweden.
Helena AvermarkDepartment of Global Public Health, Karolinska Institutet, Stockholm, Sweden.
Elisa GobboDepartment of Global Public Health, Karolinska Institutet, Stockholm, Sweden.
Sibylle Herzig van WeesDepartment of Global Public Health, Karolinska Institutet, Stockholm, Sweden.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Improving vaccine confidence is a topic of major public health importance. Reasons for vaccine hesitancy are multifactorial, making it challenging to find strategies to address them. This systematic review aimed to synthesize the literature on how co-design has been used to reduce vaccine hesitancy. We searched six databases in March and October 2024. Eligible studies described the co-design process used to develop interventions for addressing vaccine hesitancy and increasing vaccine confidence. We assessed the quality of included studies, extracted and descriptively summarized the key data. Twenty-seven articles were included, 20 of which were based in a high-income setting. Most studies centered on the COVID-19 (

Indexed as

Vaccination HesitancyCOVID-19COVID-19 VaccinesHumansPapillomavirus VaccinesVaccinationVaccinesCOVID-19 VaccinesPapillomavirus VaccinesVaccinesCo-designco-developmentinterventionsystematic reviewvaccinationvaccine confidencevaccine hesitancy

Identifiers

PMID39660656
PMCPMC11639369

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.